Peptide Guide
& Database

An FDA-approved synthetic analog of parathyroid hormone-related protein (PTHrP) that promotes bone formation and reduces fracture risk in postmenopausal osteoporosis.

A chimeric proapoptotic peptide that selectively targets the vasculature of white adipose tissue, inducing fat cell death through blood supply disruption.

A topical cosmetic peptide marketed as 'Botox in a jar' that reduces wrinkle appearance by inhibiting muscle contraction at the neuromuscular junction.

Cerebrolysin is a neuropeptide mixture derived from porcine brain proteins that mimics BDNF, GDNF, and NGF. Used clinically in 50+ countries for stroke, TBI, Alzheimer's, and dementia. Complete guide to benefits, dosage protocols, side effects, and clinical evidence.

A neuropeptide with potent anti-inflammatory and immunomodulatory properties, closely related to somatostatin but with distinct receptors and therapeutic potential.

An extremely potent cognitive-enhancing compound derived from angiotensin IV, studied for memory enhancement and potential neurodegenerative disease applications.

An FDA-approved GLP-1 receptor agonist for type 2 diabetes and cardiovascular risk reduction, administered once weekly.

The first GLP-1 receptor agonist approved for diabetes, derived from Gila monster venom, available in twice-daily and once-weekly formulations.

A myostatin inhibitor and activin-binding protein that promotes muscle growth by blocking the body's natural limiters on muscle development.

The primary hunger hormone that stimulates appetite, GH release, and gastric motility—the natural ligand for the GHS receptor targeted by GHRPs.

A potent growth hormone secretagogue that balances strong GH release with more moderate appetite stimulation than GHRP-6, making it a middle-ground option.

A potent growth hormone secretagogue known for robust GH release and significant appetite stimulation—the original GH-releasing peptide that started the secretagogue era.

The body's master antioxidant — a tripeptide critical for detoxification, oxidative stress defense, immune function, and cellular health.

The natural gonadotropin-releasing hormone used to stimulate LH and FSH production, commonly used in fertility treatment and post-cycle therapy research.

A potent synthetic growth hormone releasing hexapeptide with unique cardioprotective properties and the strongest GH release among GHRP family peptides.

The C-terminal fragment of human growth hormone responsible for fat metabolism, studied for its lipolytic activity without the growth-promoting effects of full-length HGH.

A mitochondrial-derived peptide with cytoprotective and neuroprotective properties, showing promise in aging, Alzheimer's research, and metabolic health.

A truncated, highly potent variant of IGF-1 that bypasses binding proteins for enhanced bioavailability and tissue-specific anabolic effects.

What the Long R3 modifications change: binding-protein escape, a 20–30 hour half-life, and the timing that follows from it.

A naturally-occurring dipeptide with potent anti-glycation, antioxidant, and anti-aging properties found in high concentrations in muscle and brain tissue.

A long-acting somatostatin analog for acromegaly and neuroendocrine tumors—with the convenience of self-injectable depot formulation.

An FDA-approved 14-amino acid peptide that activates guanylate cyclase-C receptors to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, with extensive clinical trial evidence supporting its metabolic benefits.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes with unique pharmacokinetics favoring postprandial glucose control.

A collagen-boosting signal peptide widely used in anti-aging skincare to reduce wrinkles and improve skin firmness.

The short-lived native form of mechano growth factor: minutes of activity, local muscle signalling, and how it differs from PEG-MGF.

An orally-active growth hormone secretagogue that mimics ghrelin signaling to increase GH and IGF-1 levels without injections.

A modified growth hormone-releasing hormone analog with enhanced stability, commonly paired with GHRPs for synergistic GH release.

An enhanced variant of Selank with improved stability and bioavailability, offering anxiolytic and cognitive effects through GABA modulation.

An enhanced variant of Semax with improved stability and potency, offering cognitive enhancement and neuroprotective effects.

An 82-amino acid peptide derived from nucleobindin-2 that regulates appetite, metabolism, and energy homeostasis through hypothalamic signaling.

A 36-amino acid neuropeptide that serves as one of the most abundant signaling molecules in the brain, regulating appetite, stress response, anxiety, and circadian rhythms.

A synthetic somatostatin analog used to treat acromegaly, carcinoid tumors, and severe diarrhea—one of the most clinically important peptide drugs in endocrinology.

A neuropeptide critical for wakefulness, appetite regulation, and energy homeostasis with therapeutic implications for narcolepsy and metabolic disorders.

A synthetic 21-amino acid peptide derived from Ciliary Neurotrophic Factor (CNTF) that promotes neurogenesis and cognitive enhancement.

A 38-amino acid neuropeptide with potent neuroprotective, anti-inflammatory, and regenerative properties across multiple organ systems.

A pegylated variant of IGF-1 splice variant with extended half-life, studied for localized muscle repair and hypertrophy signaling.

A GLP-1/glucagon dual agonist designed for better body composition—promoting fat loss while preserving muscle mass during weight loss.

A gut-derived satiety hormone that reduces appetite and regulates energy balance, with significant research implications for obesity treatment.

An FDA-approved synthetic amylin analog that complements insulin therapy by slowing gastric emptying, reducing glucagon secretion, and enhancing satiety in diabetes management.

A cell-penetrating peptide targeting the Wnt/β-catenin pathway to activate hair follicle stem cells and promote hair regrowth.

An FDA-approved MC4R agonist peptide for treating obesity caused by rare genetic disorders affecting the leptin-melanocortin pathway.

An 8-amino acid peptide that mimics the N-terminus of SNAP-25 to reduce muscle contractions and soften expression lines without injections.

A dual GLP-1 and glucagon receptor agonist showing significant weight loss and liver fat reduction in clinical trials, positioned as a next-generation obesity and MASH therapeutic.

An FDA-approved parathyroid hormone analog used to treat osteoporosis by stimulating new bone formation rather than just preventing bone loss.

A thymic polypeptide bioregulator with immunomodulatory and geroprotective properties, developed from decades of Russian peptide bioregulation research.

A synthetic pentapeptide derived from thymopoietin that modulates T-cell function and enhances immune system regulation.

A 43-amino acid protein that orchestrates tissue repair, cell migration, and wound healing—the full molecule behind TB-500's regenerative reputation.

A zinc-dependent thymic nonapeptide essential for T-cell maturation, immune regulation, and emerging anti-aging research.

An FDA-approved modified C-type natriuretic peptide (CNP) analog that promotes bone growth by counteracting FGFR3 signaling in children with achondroplasia.